Frequency, prognosis and treatment modalities of newly diagnosed small bowel cancer with liver metastases
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-230X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Frequency, prognosis and treatment modalities of newly diagnosed small bowel cancer with liver metastases ; volume:20 ; number:1 ; day:15 ; month:10 ; year:2020 ; pages:1-14 ; date:12.2020
BMC gastroenterology ; 20, Heft 1 (15.10.2020), 1-14, 12.2020
- Urheber
-
Ye, Xiaorong
Wang, Lifu
Xing, Yongjun
Song, Chengjun
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12876-020-01487-6
- URN
-
urn:nbn:de:101:1-2020112920205562559848
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:37 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Ye, Xiaorong
- Wang, Lifu
- Xing, Yongjun
- Song, Chengjun
- SpringerLink (Online service)
Ähnliche Objekte (12)
Paneth cell metaplasia in newly diagnosed inflammatory bowel disease in children
Comparison between newly diagnosed hypertension in diabetes and newly diagnosed diabetes in hypertension
Temporal muscle thickness is an independent prognostic marker in melanoma patients with newly diagnosed brain metastases
Impact of Concomitant Prescriptions and Lifestyle Factors on the Initial Course of Newly Diagnosed Inflammatory Bowel Disease
Interstitial photodynamic therapy for newly diagnosed glioblastoma
Chronic Diarrhea Secondary to Newly Diagnosed VIPoma
Assessing novel modalities for the therapy of inflammatory bowel disease
Risk factors of distant brain failure for patients with newly diagnosed brain metastases treated with stereotactic radiotherapy alone
Symptoms and symptom clusters in patients newly diagnosed with inflammatory bowel disease: results from the IBSEN III Study
Dysbiosis, inflammation, and response to treatment: a longitudinal study of pediatric subjects with newly diagnosed inflammatory bowel disease
Survival prediction using temporal muscle thickness measurements on cranial magnetic resonance images in patients with newly diagnosed brain metastases
Prognostic assessment in patients with newly diagnosed small cell lung cancer brain metastases: results from a real-life cohort
Paneth cell metaplasia in newly diagnosed inflammatory bowel disease in children
Comparison between newly diagnosed hypertension in diabetes and newly diagnosed diabetes in hypertension
Temporal muscle thickness is an independent prognostic marker in melanoma patients with newly diagnosed brain metastases
Impact of Concomitant Prescriptions and Lifestyle Factors on the Initial Course of Newly Diagnosed Inflammatory Bowel Disease
Interstitial photodynamic therapy for newly diagnosed glioblastoma
Chronic Diarrhea Secondary to Newly Diagnosed VIPoma
Assessing novel modalities for the therapy of inflammatory bowel disease
Risk factors of distant brain failure for patients with newly diagnosed brain metastases treated with stereotactic radiotherapy alone
Symptoms and symptom clusters in patients newly diagnosed with inflammatory bowel disease: results from the IBSEN III Study
Dysbiosis, inflammation, and response to treatment: a longitudinal study of pediatric subjects with newly diagnosed inflammatory bowel disease
Survival prediction using temporal muscle thickness measurements on cranial magnetic resonance images in patients with newly diagnosed brain metastases
Prognostic assessment in patients with newly diagnosed small cell lung cancer brain metastases: results from a real-life cohort
Paneth cell metaplasia in newly diagnosed inflammatory bowel disease in children
Comparison between newly diagnosed hypertension in diabetes and newly diagnosed diabetes in hypertension
Temporal muscle thickness is an independent prognostic marker in melanoma patients with newly diagnosed brain metastases
Impact of Concomitant Prescriptions and Lifestyle Factors on the Initial Course of Newly Diagnosed Inflammatory Bowel Disease
Interstitial photodynamic therapy for newly diagnosed glioblastoma
Chronic Diarrhea Secondary to Newly Diagnosed VIPoma
Assessing novel modalities for the therapy of inflammatory bowel disease
Risk factors of distant brain failure for patients with newly diagnosed brain metastases treated with stereotactic radiotherapy alone
Symptoms and symptom clusters in patients newly diagnosed with inflammatory bowel disease: results from the IBSEN III Study
Dysbiosis, inflammation, and response to treatment: a longitudinal study of pediatric subjects with newly diagnosed inflammatory bowel disease
Survival prediction using temporal muscle thickness measurements on cranial magnetic resonance images in patients with newly diagnosed brain metastases